Net Worth Advisory Group’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-1,208
Closed -$390K 453
2025
Q3
$390K Sell
1,208
-26
-2% -$8.09K 0.11% 200
2025
Q2
$480K Sell
1,234
-3
-0.2% -$1.21K 0.11% 197
2025
Q1
$538K Buy
1,237
+5
+0.4% +$2.01K 0.17% 147
2024
Q4
$454K Sell
1,232
-322
-21% -$135K 0.14% 185
2024
Q3
$808K Buy
+1,554
New +$830K 0.24% 81

Other funds holding ELV

Net Worth Advisory Group's ELV Position: Q4 2025 in Review

Net Worth Advisory Group sold out of Elevance Health (ELV) in Q4 2025, closing a stake of 1,208 shares — an estimated $390K sold.

Net Worth Advisory Group first reported a position in ELV in Q3 2024 and held it in 5 quarters. The position peaked at $808K in Q3 2024. 1,555 funds tracked by Wall St. Rank hold ELV as of Q4 2025.

  • Net Worth Advisory Group reported no remaining Elevance Health position as of Q4 2025 after selling out during the quarter.
  • Net Worth Advisory Group sold 1,208 Elevance Health shares in Q4 2025, an estimated $390K.
  • Net Worth Advisory Group first reported a position in Elevance Health in Q3 2024 and held it in 5 quarters.
  • Net Worth Advisory Group's Elevance Health position peaked at $808K in Q3 2024.
  • 1,555 funds tracked by Wall St. Rank held Elevance Health as of Q4 2025.

Based on Net Worth Advisory Group's 13F filing for Q4 2025, filed 14 Jan 2026.